the aid library

LIST OPTIONS

Filter

8288

Clinical management of COVID-19: Living guideline, 15 September 2022
recommended

World Health Organization WHO (2022) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ... more

Download (377)

View PDF (439)

Living Planet Report 2020 - Bending the curve of biodiversity loss

World Wildlife Fund for Nature WWF (2020) C2

At a time when the world is reeling from the deepest global disruption and health crisis of a lifetime, this year’s Living Planet report provides unequivocal and alarming evidence that nature is unraveling and that our planet is flashing red warning signs of vital natural systems failure. The ... more

Download (411)

View PDF (527)

Disability: recommendations for eye programmes

Colin Cook, Babar Qureshi, Harpreet Kapoor, Dominic Misquith, and David Lewis Community Eye Health Journal (2013) CC

Recommendations on the inclusion of people with disabilities in eye care made by CBM's Medical Eye Care Advisory Group as a result of a meeting in Hydrabad, India, in 2012.

Download (345)

View PDF (645)

Not all that bleeds is Ebola
recommended

International Rescue Committee (2020) C1

How has the DRC Ebola outbreak impacted Sexual and Reproductive Health in North-Kivu? Recommendations (more specifics found in the assessment): 1. Sexual and reproductive health needs and services are to be embedded in the EVD response from the outset. 2. Reduce delays at every stage of the patie... more

External Link

Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries

Hsia Y., B. R Lee, A. Versporten, et al The Lancet (2019) C2

Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally.... more

Download (434)

View PDF (602)

Drugs to prevent COVID-19: living guideline

World Health Organisation (WHO) (2023) C_WHO

The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform. Guidelines ... more

Download (390)

View PDF (533)

Ukrainian Prioritized Multisectoral Mental Health and Psychosocial Support Actions During and After the War: Operational Roadmap

World Health Organisation (WHO) (2022) C_WHO

The development of this Operational Roadmap has been driven by a growing consensus in Ukraine on the need to prioritize activities that are urgently required to address the mental health and psychosocial needs of the country’s population and also the importance of basing the response on existing s...tructures, resources and innovations introduced in reforms in past years. According to this consensus, new resources mobilized by and for Ukraine should complement existing ones, in line with the national vision and with best international standards, and should be planned in a way that further strengthens the country’s mental health system. The Government of Ukraine is committed to urgently addressing the mental health and psychosocial needs of the population, under the auspices of the First Lady of Ukraine and the leadership of the recently established Intersectoral Coordination Council for Mental Health and Psychological Assistance to Victims of the Armed Aggression of the Russian Federation against Ukraine (referred to in this document as the Intersectoral Coordination Council). This Roadmap has been developed following a series of consultations with Ukrainian authorities and national and international agencies working in the area of mental health and psychosocial support (MHPSS) and engaged in emergency response in Ukraine. The consultation process was organized by the Ministry of Health of Ukraine (MOH) and supported by WHO Ukraine, under the auspices of the First Lady of Ukraine and in collaboration with the MHPSS Technical Working Group of Ukraine (MHPSS TWG Ukraine) and the IASC MHPSS Reference Group (IASC MHPSS RG), and building on substantial advances in the mental health sector under existing programmes in the country. The Roadmap is informed by international technical guidance and national policies and plans, including the IASC Guidelines on MHPSS in Emergency Settings, the Minimum Services Package for MHPSS in Emergencies (MHPSS MSP), the IASC Common Monitoring and Evaluation Framework, the World Health Organization (WHO)’s Comprehensive Mental Health Action Plan 2013– 2030, the WHO European Framework for Action on Mental Health, the Concept for Development of Mental Health Care in Ukraine until 2030, the National Mental Health Action Plan for 2021–2023 and the National Recovery and Development Plan. Informed by the overall goal of MHPSS assistance in Ukraine – to reduce suffering and improve the mental health and psychosocial well-being of the affected population – the Roadmap aims to provide a consolidated overview of envisioned MHPSS priorities, informed by the local context and the vision of the Government of Ukraine together with national and international partners, and with the best available evidence and resources, to all MHPSS stakeholders already engaged in or joining emergency response and recovery efforts in Ukraine. As well as information on the context in Ukraine, the Roadmap includes: • a list of evidence-based MHPSS interventions and services contextualized and introduced in Ukraine in recent years (described in Table 1) and • a set of multisectoral actions to scale up MHPSS services in both the short and longer terms, informed by available evidence, international technical guidance and expert consensus (described in Table 2). more

Download (403)

View PDF (443)

Strengthening the Assessment of Lymphatic Filariasis Transmission and documenting the Achievement of Elimination

World Health Organization WHO (2014) C_WHO

Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators

Download (366)

View PDF (382)

Weekly epidemiological update on COVID-19 - 4 January 2023

World Health Organization WHO (2023) C_WHO

Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov... more

Download (1410)

View PDF (1631)

Medicinal products under development for the treatment of Ebola

European Medicines Agency EMA (2014)

Interim Assessement Report The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte... more

Download (319)

View PDF (385)

Review of forest and landscape restoration in Africa 2021

Food and Agricultur Organization of the United Nations FAO and NEPAD (2021) C2

English Analysis on World about Agriculture, Climate Change and Environment and more; published on 29 Sep 2021 by FAO and NEPAD

Download (511)

View PDF (683)

Interactive Atlas of Leishmaniasis in the Americas: Clinical Aspects and Differential Diagnosis

Pan American Health Organisation PAHO (2021) C_WHO

In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti... more

Download (339)

View PDF (382)

HUMANITARIAN RESPONSE PLAN 2018-2019 (Revised following Cyclone Idai, March 2019)

OCHA OCHA (2019) CC

This document is produced by the Humanitarian Country Team and the United Nations Resident Coordinator’s Office in Mozambique, with the support of the United Nations Office for the Coordination of Humanitarian Affairs (OCHA). The projects reflected here support the national government. It covers... more

Download (301)

View PDF (266)

Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso

Ouedraogo Y., Furlane G., Fruhauf T. et al. Global Health: Science and Practice (2018) CC

Background: Cervical cancer accounts for 23% of cancer incidence and 22% of cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those of developed countries, respectively. Before 2010, cervical cancer prevention (CECAP) services in Burkina Faso wer...e limited to temporary screening campaigns. Program Description: Between September 2010 and August 2014, program implementers collaborated with the Ministry of Health and professional associations to implement a CECAP program focused on coupling visual inspection with acetic acid (VIA) for screening with same-day cryotherapy treatment for eligible women in 14 facilities. Women with larger lesions or lesions suspect for cancer were referred for loop electrosurgical excision procedure (LEEP). The program trained providers, raised awareness through demand generation activities, and strengthened monitoring capacity. Methods: Data on program activities, service provision, and programmatic lessons were analyzed. Three data collection tools, an individual client form, a client registry, and a monthly summary sheet, were used to track 3 key CECAP service indicators: number of women screened using VIA, proportion of women who screened VIA positive, and proportion of women screening VIA positive who received same-day cryotherapy. Results: Over 4 years, the program screened 13,999 women for cervical cancer using VIA; 8.9% screened positive; and 65.9% received cryotherapy in a single visit. The proportion receiving cryotherapy on the same day started at a high of 82% to 93% when services were provided free of charge, but dropped to 51% when a user fee of $10 was applied to cover the cost of supplies. After reducing the fee to $4 in November 2012, the proportion increased again to 78%. Implementation challenges included difficulties tracking referred patients, stock-outs of key supplies, difficulties with machine maintenance, and prohibitive user fees. Providers were trained to independently monitor services, identify gaps, and take corrective actions. Conclusions: Following dissemination of the results that demonstrated the acceptability and feasibility of the CECAP program, the Burkina Faso Ministry of Health included CECAP services in its minimum service delivery package in 2016. Essential components for such programs include provider training on VIA, cryotherapy, and LEEP; provider and patient demand generation; local equipment maintenance; consistent supply stocks; referral system for LEEP; non-prohibitive fees; and a monitoring data collection system. more

Download (236)

View PDF (346)

C20 Eight Proposed Recommendations for Effective G20 Agenda on Finance and Health

Civil Society 20 (C20) - Saudi Arabia 2020 (2020) CC

As a global community of +750 representatives of the world’s civil society, the C20 official Engagement Group of the G20 is submitting a list of policy priorities for the upcoming G20 Finance Ministers & Central Bank Governors meeting on July 18th and the G20 Extraordinary Sherpa Meeting on July 2... more

Download (1018)

View PDF (1088)

Antidepressants (Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors) in treatment of adults with depression

World Health Organization WHO (2012) C_WHO

Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?

External Link

Cancer of the cervix

Hesperian (2021) CC

A Book for Midwives > Chapter 20: The Pelvic Exam: how to examine a woman's vagina and womb > Cancer of the cervix

External Link

The successful COVID-19 vaccine rollout in Chile: Factors and challenges

Castillo C., Villalobos Dintrans P. et al (2021) C2

The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p... more

Download (462)

View PDF (417)

Policy brief on tuberculosis-associated disability

World Health Organization WHO (2023) C_WHO

People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ... more

Download (424)

View PDF (506)

EPIDEMIOLOGY OF MUSCULOSKELETAL DISORDERS IN PRIMARY SCHOOL CHILDREN IN BOSNIA AND HERZEGOVINA

Selma Azabagic, Razija Spahic, Nurka Pranjic, and Maida Mulic materia socio-medica (2016) CC

Musculoskeletal disorders represent a significant problem of modern society which are more pronounced in young people and school children. Etiology of these disorders is found in inadequate ergonomic conditions, too heavy school bag, school furniture inadequate to age, poor posture, sedentary lifest... more

Clinical management of COVID-19: Living guideline, 15 September 2022 recommended

Not all that bleeds is Ebola recommended

Clinical management of COVID-19: Living guideline, 15 September 2022
recommended

Not all that bleeds is Ebola
recommended